Claire Hentzen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Claire Hentzen has a total of 183 co-authors. Here are the top co-authors by number of shared publications:
- Camille Chesnel
Sorbonne Université, GRC‐01 GREEN Service de Neuro‐urologie, Hôpital Pitié Salpêtrière Paris France
14 shared publications Gérard Amarenco
Sorbonne Université, GRC‐01 GREEN Service de Neuro‐urologie, Hôpital Pitié Salpêtrière Paris France
13 shared publications- Gérard Amarenco
Sorbonne Université, GRC 001, GREEN Groupe de Recherche Clinique en Neuro-Urologie, AP-HP, hôpital Tenon, 75020 Paris, France
12 shared publications - Nicolas Turmel
Sorbonne Université, GRC 001, GREEN Groupe de Recherche Clinique en Neuro-Urologie, AP-HP, hôpital Tenon, 75020 Paris, France
9 shared publications - Rebecca Haddad
Groupe de recherche clinique en neuro-urologie, Hôpital Rothschild, AP-HP, Paris, France
9 shared publications Camille Chesnel
Sorbonne University, GRC 01, GREEN Group of clinical REsEarch in Neurourology, AP-HP, Hôpital Pitié Salpêtrière, Paris, 75013, France
8 shared publications
Latest Publications
- 18 September 2026
- Published by Springer Nature in World Journal of Urology
- Vol. 44 (1) , 674
The role of urodynamics in overactive bladder: a critical in-depth analysis of the FUTURE study
The FUTURE study, a large randomised controlled trial in women with refractory overactive bladder, concluded that urodynamics does not improve outcomes when added to clinical assessment and is not cost-effective. These findings have been presented as justification for abandoning urodynamics in this large and heterogeneous patient population. In this paper, we undertake a detailed appraisal of the FUTURE study, examining its overarching research premise, the design and methodology it employed to evaluate the clinical utility of urodynamics and the way in which its findings were reported and interpreted by the authors. We conclude that significant conceptual and methodological limitations undermine the validity of the study and the reliability and generalisability of the data. Consequently, changes in clinical practice are not justified on the basis of the FUTURE study.
- 18 September 2026
- Published by Springer Nature in World Journal of Urology
- Vol. 44 (1) , 674
The role of urodynamics in overactive bladder: a critical in-depth analysis of the FUTURE study
The FUTURE study, a large randomised controlled trial in women with refractory overactive bladder, concluded that urodynamics does not improve outcomes when added to clinical assessment and is not cost-effective. These findings have been presented as justification for abandoning urodynamics in this large and heterogeneous patient population. In this paper, we undertake a detailed appraisal of the FUTURE study, examining its overarching research premise, the design and methodology it employed to evaluate the clinical utility of urodynamics and the way in which its findings were reported and interpreted by the authors. We conclude that significant conceptual and methodological limitations undermine the validity of the study and the reliability and generalisability of the data. Consequently, changes in clinical practice are not justified on the basis of the FUTURE study.
- Open Access
- 22 June 2026
- Published by Wiley in Neurourology and Urodynamics
- Vol. 45 (8) , 1569-1577
Urodynamic Voiding Patterns in Multiple Sclerosis
Aims: This study aimed to describe urodynamic voiding patterns in patients with MS (PwMS) using standardized assessments, and to compare the performance of the available nomograms and indices for obstruction and bladder contractility. Methods: PwMS and lower urinary tract symptoms underwent cystometry and pressure flow studies. Fluoroscopy findings were collected when available. Bladder contractility was assessed using the following parameters: bladder voiding efficiency (BVE), bladder contractility index (BCI), Watts factor (WF) for men, Projected Isovolumetric Pressure 1 (PIP1), the Valentini−Besson−Nelson (VBN) parameter k, and the urodynamic cut‐off proposed by Gammie et al. for women. Obstruction was assessed using the bladder outlet obstruction index (BOOI) in men, and BOOIf in women. Agreement between the diagnosis of detrusor underactivity (DUA) and obstruction according to each parameter was assessed with weight kappa. Results: Ninety‐seven PwMS were included (mean age 48.4 ± 10.5, 58 [60%] women, mean EDSS 3.9 ± 1.8). Sphincter dysfunction was observed in 68 patients (70%), most frequently detrusor sphincter dyssynergia (DSD) in 32 (33%), followed by non‐relaxing urethral sphincter in 29 (30%), and delayed relaxation of the urethral sphincter in 7 (7%) PwMS. DUA was found in 22 PwMS (23%). All indices demonstrated low to moderate agreement with the diagnosis of DUA and obstruction in this cohort. Conclusion: Abnormal voiding patterns are common in PwMS, especially sphincter dysfunction. None of the developed indices for obstruction and DUA appear highly relevant in this specific neurogenic population.
- 22 June 2026
- Published by Wiley in Neurourology and Urodynamics
- Vol. 45 (8) , 1569-1577
Open AccessUrodynamic Voiding Patterns in Multiple Sclerosis
Aims: This study aimed to describe urodynamic voiding patterns in patients with MS (PwMS) using standardized assessments, and to compare the performance of the available nomograms and indices for obstruction and bladder contractility. Methods: PwMS and lower urinary tract symptoms underwent cystometry and pressure flow studies. Fluoroscopy findings were collected when available. Bladder contractility was assessed using the following parameters: bladder voiding efficiency (BVE), bladder contractility index (BCI), Watts factor (WF) for men, Projected Isovolumetric Pressure 1 (PIP1), the Valentini−Besson−Nelson (VBN) parameter k, and the urodynamic cut‐off proposed by Gammie et al. for women. Obstruction was assessed using the bladder outlet obstruction index (BOOI) in men, and BOOIf in women. Agreement between the diagnosis of detrusor underactivity (DUA) and obstruction according to each parameter was assessed with weight kappa. Results: Ninety‐seven PwMS were included (mean age 48.4 ± 10.5, 58 [60%] women, mean EDSS 3.9 ± 1.8). Sphincter dysfunction was observed in 68 patients (70%), most frequently detrusor sphincter dyssynergia (DSD) in 32 (33%), followed by non‐relaxing urethral sphincter in 29 (30%), and delayed relaxation of the urethral sphincter in 7 (7%) PwMS. DUA was found in 22 PwMS (23%). All indices demonstrated low to moderate agreement with the diagnosis of DUA and obstruction in this cohort. Conclusion: Abnormal voiding patterns are common in PwMS, especially sphincter dysfunction. None of the developed indices for obstruction and DUA appear highly relevant in this specific neurogenic population.
- Open Access
- 10 April 2026
- Published by Elsevier in Autonomic Neuroscience
- Vol. 265, 103421
Autonomic dysfunction in patients with lower urinary tract disorders
- 10 April 2026
- Published by Elsevier in Autonomic Neuroscience
- Vol. 265, 103421
Open AccessAutonomic dysfunction in patients with lower urinary tract disorders
- 8 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Influence de la sensibilité vésicale et urétrale et de ses troubles dans le cycle continence miction du patient neurologique
Introduction : Le fonctionnement vésico sphinctérien est sous contrôle intégral du système nerveux somatique et végétatif, avec des relais médullaires, pontiques et encéphaliques, expliquant la fréquence des troubles vésico sphinctériens dans les pathologies neurologiques, à la fois sur la phase de continence et sur la miction. Les afférences sensitives semblent jouer un rôle important dans la genèse des troubles.L'objectif de cette thèse était de rechercher s'il existe une association entre les modalités de perception du besoin et l'existence et la sévérité des troubles urinaires chez les patients neurologiques.Méthodes :Afin d'évaluer d'abord l'impact des conditions de remplissage sur les sensations vésicales et l'efficience mictionnelle, une étude rétrospective comparant les volumes d'apparition du besoin et les paramètres des études pression-débit selon trois conditions différentes chez des patients avec scléroses en plaques a été menée. Tous les patients ayant bénéficié d'un bilan urodynamique comprenant un remplissage lent à 20 ml/min, un remplissage rapide à 100 ml/min, et un remplissage rapide à 100 ml/min avec de l'eau à 4°C ont été inclus. Le volume d'apparition des différents besoins et les paramètres de la miction ont été comparés par des analyses appariées.Secondairement, la corrélation entre la cinétique d'apparition des besoins au cours du remplissage et la sévérité clinique de l'hyperactivité vésicale chez les patients avec sclérose en plaques a été évaluée rétrospectivement. Le volume entre l'apparition du premier besoin et du besoin important d'uriner a été calculé pour chaque patient, et corrélé à la sévérité de l'hyperactivité vésicale mesurée par le questionnaire Urinary Symptom Profile et un catalogue mictionnel.Enfin, chez les patients ayant bénéficié d'un traitement par stimulation du nerf tibial, dont le mécanisme supposé est une action sur les afférences sensitives, et d'une nouvelle évaluation urodynamique, l'impact de ce traitement sur les paramètres de sensibilité urodynamique (volume de perception des besoin) et clinique (sévérité de l'hyperactivité vésicale) a été évalué.Résultats :La première étude a inclus 157 patients avec sclérose en plaques. L'augmentation de la vitesse de remplissage était responsable d'un retard à la perception des besoins d'uriner (Premier besoin B1 219±109 ml vs. 194±100 ml, besoin important B3 349±113 ml vs. 322±124 ml, p < 0,001), tandis que l'eau glacée entrainait l'apparition plus précoce des premier besoin et besoin urgent (B1 : 163±99ml vs. 218±117 ml; B3 : 263±104 ml vs. 351±112 ml, p<0,001). En revanche le volume d'apparition de l'hyperactivité détrusorienne n'était pas modifié. En phase mictionnelle, l'eau glacée entrainait une diminution du débit urinaire sans rétention significativement plus importante.La seconde étude a inclus 202 patients, dont 98 ne présentant pas d'hyperactivité détrusorienne. Une corrélation faible mais significative entre le volume B1-B3 et le score USP hyperactivité vésicale (rho=0,32 ; p<0,01), en particulier avec l'item relatif au délai de sécurité (rho=0,38 ; p<0,01) a été retrouvée.Enfin, sur les 82 patients inclus dans l'évaluation du traitement par stimulation du nerf tibial, une amélioration clinique des différents paramètres d'hyperactivité vésicale a été retrouvé (diminution du score USP (7,7±3,5 vs. 6,0±3,4 (p<0,0001), fréquence mictionnelle, proportion de mictions réalisées sur un besoin urgent, p<0,05). Pour autant il n'a pas été retrouvé de modification des paramètres urodynamiques, à la fois sur la phase de continence et sur la miction.Conclusion :La sensibilité vésicale et la perception des différents besoins est variable en fonction des outils et conditions d'examen. La cinétique d'apparition des besoins semble jouer un rôle dans la sévérité de l'hyperactivité vésicale chez le patient neurologique, mais de nombreux autres paramètres sensitifs sont probablement impliqués et restent à étudier.
- 8 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Influence de la sensibilité vésicale et urétrale et de ses troubles dans le cycle continence miction du patient neurologique
Introduction : Le fonctionnement vésico sphinctérien est sous contrôle intégral du système nerveux somatique et végétatif, avec des relais médullaires, pontiques et encéphaliques, expliquant la fréquence des troubles vésico sphinctériens dans les pathologies neurologiques, à la fois sur la phase de continence et sur la miction. Les afférences sensitives semblent jouer un rôle important dans la genèse des troubles.L'objectif de cette thèse était de rechercher s'il existe une association entre les modalités de perception du besoin et l'existence et la sévérité des troubles urinaires chez les patients neurologiques.Méthodes :Afin d'évaluer d'abord l'impact des conditions de remplissage sur les sensations vésicales et l'efficience mictionnelle, une étude rétrospective comparant les volumes d'apparition du besoin et les paramètres des études pression-débit selon trois conditions différentes chez des patients avec scléroses en plaques a été menée. Tous les patients ayant bénéficié d'un bilan urodynamique comprenant un remplissage lent à 20 ml/min, un remplissage rapide à 100 ml/min, et un remplissage rapide à 100 ml/min avec de l'eau à 4°C ont été inclus. Le volume d'apparition des différents besoins et les paramètres de la miction ont été comparés par des analyses appariées.Secondairement, la corrélation entre la cinétique d'apparition des besoins au cours du remplissage et la sévérité clinique de l'hyperactivité vésicale chez les patients avec sclérose en plaques a été évaluée rétrospectivement. Le volume entre l'apparition du premier besoin et du besoin important d'uriner a été calculé pour chaque patient, et corrélé à la sévérité de l'hyperactivité vésicale mesurée par le questionnaire Urinary Symptom Profile et un catalogue mictionnel.Enfin, chez les patients ayant bénéficié d'un traitement par stimulation du nerf tibial, dont le mécanisme supposé est une action sur les afférences sensitives, et d'une nouvelle évaluation urodynamique, l'impact de ce traitement sur les paramètres de sensibilité urodynamique (volume de perception des besoin) et clinique (sévérité de l'hyperactivité vésicale) a été évalué.Résultats :La première étude a inclus 157 patients avec sclérose en plaques. L'augmentation de la vitesse de remplissage était responsable d'un retard à la perception des besoins d'uriner (Premier besoin B1 219±109 ml vs. 194±100 ml, besoin important B3 349±113 ml vs. 322±124 ml, p < 0,001), tandis que l'eau glacée entrainait l'apparition plus précoce des premier besoin et besoin urgent (B1 : 163±99ml vs. 218±117 ml; B3 : 263±104 ml vs. 351±112 ml, p<0,001). En revanche le volume d'apparition de l'hyperactivité détrusorienne n'était pas modifié. En phase mictionnelle, l'eau glacée entrainait une diminution du débit urinaire sans rétention significativement plus importante.La seconde étude a inclus 202 patients, dont 98 ne présentant pas d'hyperactivité détrusorienne. Une corrélation faible mais significative entre le volume B1-B3 et le score USP hyperactivité vésicale (rho=0,32 ; p<0,01), en particulier avec l'item relatif au délai de sécurité (rho=0,38 ; p<0,01) a été retrouvée.Enfin, sur les 82 patients inclus dans l'évaluation du traitement par stimulation du nerf tibial, une amélioration clinique des différents paramètres d'hyperactivité vésicale a été retrouvé (diminution du score USP (7,7±3,5 vs. 6,0±3,4 (p<0,0001), fréquence mictionnelle, proportion de mictions réalisées sur un besoin urgent, p<0,05). Pour autant il n'a pas été retrouvé de modification des paramètres urodynamiques, à la fois sur la phase de continence et sur la miction.Conclusion :La sensibilité vésicale et la perception des différents besoins est variable en fonction des outils et conditions d'examen. La cinétique d'apparition des besoins semble jouer un rôle dans la sévérité de l'hyperactivité vésicale chez le patient neurologique, mais de nombreux autres paramètres sensitifs sont probablement impliqués et restent à étudier.
- Open Access
- 9 December 2025
- Published by Wiley in Neurourology and Urodynamics
- Vol. 45 (5) , 895-903
Phenotyping Overactive Bladder—Part 1: Are There Different Types of Urgency and Can They be Translated to Clinical, Urodynamic and Radiological Phenotyping? ICI‐RS 2025
Introduction: Overactive bladder (OAB) is defined as urinary urgency, usually accompanied by increased daytime frequency and/or nocturia, with urgency urinary incontinence (OAB‐wet) or without (OAB‐dry), in the absence of urinary tract infection or other detectable disease. The key symptom of OAB, urinary urgency, is defined as a complaint of sudden, compelling desire to pass urine which is difficult to defer. However, patients report a range of individual experiences and sensations associated with urgency and studies have identified different types of urgency. Patients with OAB not only differ in clinical presentation, but also have different urodynamic and radiological findings. These variations may explain why OAB treatments work well for some individuals but not others. This paper investigates how knowledge can be advanced by phenotyping OAB by urgency symptom variation, and clinical, urodynamic measurements and radiological features. Methods: A Think Tank at the International Consultation on Incontinence‐Research Society (ICI‐RS) 2025 discussed the question, “Can OAB management be improved by phenotyping if there are different types of urgency?” The group discussed the current literature on this topic and developed a list of research questions to help shape the future of the field. Results: Clinical, urodynamic and radiological phenotyping of urgency were discussed and research studies to phenotype urgency were proposed. Conclusion: Further research to phenotype OAB beyond the presence or absence of urgency and urgency urinary incontinence, using clinical, urodynamic measurements and radiological features, is needed. High priority research questions and strategies were defined. Advanced OAB phenotyping may guide tailored management beyond a stepwise approach, with the aim to improve therapeutic outcomes. This would validate phenotyping and is explored in Part 2 of the topic.
- 9 December 2025
- Published by Wiley in Neurourology and Urodynamics
- Vol. 45 (5) , 895-903
Open AccessPhenotyping Overactive Bladder—Part 1: Are There Different Types of Urgency and Can They be Translated to Clinical, Urodynamic and Radiological Phenotyping? ICI‐RS 2025
Introduction: Overactive bladder (OAB) is defined as urinary urgency, usually accompanied by increased daytime frequency and/or nocturia, with urgency urinary incontinence (OAB‐wet) or without (OAB‐dry), in the absence of urinary tract infection or other detectable disease. The key symptom of OAB, urinary urgency, is defined as a complaint of sudden, compelling desire to pass urine which is difficult to defer. However, patients report a range of individual experiences and sensations associated with urgency and studies have identified different types of urgency. Patients with OAB not only differ in clinical presentation, but also have different urodynamic and radiological findings. These variations may explain why OAB treatments work well for some individuals but not others. This paper investigates how knowledge can be advanced by phenotyping OAB by urgency symptom variation, and clinical, urodynamic measurements and radiological features. Methods: A Think Tank at the International Consultation on Incontinence‐Research Society (ICI‐RS) 2025 discussed the question, “Can OAB management be improved by phenotyping if there are different types of urgency?” The group discussed the current literature on this topic and developed a list of research questions to help shape the future of the field. Results: Clinical, urodynamic and radiological phenotyping of urgency were discussed and research studies to phenotype urgency were proposed. Conclusion: Further research to phenotype OAB beyond the presence or absence of urgency and urgency urinary incontinence, using clinical, urodynamic measurements and radiological features, is needed. High priority research questions and strategies were defined. Advanced OAB phenotyping may guide tailored management beyond a stepwise approach, with the aim to improve therapeutic outcomes. This would validate phenotyping and is explored in Part 2 of the topic.
- Open Access
- 26 November 2025
- Published by Wiley in Neurourology and Urodynamics
- Vol. 45 (5) , 937-944
Which Patients With Dysfunctional Voiding Respond Well to Sacral Neuromodulation? ICI‐RS 2025
Aims: Dysfunctional voiding (DV) is characterised by fluctuating or intermittent urinary flow during voiding in neurologically normal individuals. Given the different definitions used and heterogeneous pathophysiologies, outcomes following sacral neuromodulation/sacral nerve stimulation (SNM/SNS) are variably reported. The aim was to identify the areas of research required to be able to accurately predict response to SNM/SNS in adults with DV. Methods: The relevant literature was reviewed by a multidisciplinary panel and the findings were discussed at the ICI‐RS meeting held in 2025 in the UK. The outcomes of this discussion are presented. Results: DV has unique diagnostic features, typically requiring pressure‐flow studies and uroflowmetry to establish the diagnosis. Further investigations such as electromyography and urethral pressure profilometry help to better understand the pathophysiology. Phenotyping the lower urinary tract dysfunction helps to identify patterns of abnormalities, and it is likely that certain groups show a better response to SNM/SNS than others, such as in Fowler's syndrome. Older age and change in body weight following implantation are associated with a worse outcome, though not specifically in DV. Studies evaluating the impact of neuropsychiatric co‐morbidities on SNM/SNS outcomes show mixed results. Central dysregulation of micturition networks possibly contribute to DV and could represent an additional therapeutic target of SNM. Conclusion: Precise phenotyping of individuals with DV integrating clinical, urodynamic, neurophysiological, and neuropsychiatric factors is essential to predict which adults respond best to SNM/SNS. Future research should focus on establishing criteria for patient selection and designing comprehensive prospective interventional studies to assess efficacy and complications.
- 26 November 2025
- Published by Wiley in Neurourology and Urodynamics
- Vol. 45 (5) , 937-944
Open AccessWhich Patients With Dysfunctional Voiding Respond Well to Sacral Neuromodulation? ICI‐RS 2025
Aims: Dysfunctional voiding (DV) is characterised by fluctuating or intermittent urinary flow during voiding in neurologically normal individuals. Given the different definitions used and heterogeneous pathophysiologies, outcomes following sacral neuromodulation/sacral nerve stimulation (SNM/SNS) are variably reported. The aim was to identify the areas of research required to be able to accurately predict response to SNM/SNS in adults with DV. Methods: The relevant literature was reviewed by a multidisciplinary panel and the findings were discussed at the ICI‐RS meeting held in 2025 in the UK. The outcomes of this discussion are presented. Results: DV has unique diagnostic features, typically requiring pressure‐flow studies and uroflowmetry to establish the diagnosis. Further investigations such as electromyography and urethral pressure profilometry help to better understand the pathophysiology. Phenotyping the lower urinary tract dysfunction helps to identify patterns of abnormalities, and it is likely that certain groups show a better response to SNM/SNS than others, such as in Fowler's syndrome. Older age and change in body weight following implantation are associated with a worse outcome, though not specifically in DV. Studies evaluating the impact of neuropsychiatric co‐morbidities on SNM/SNS outcomes show mixed results. Central dysregulation of micturition networks possibly contribute to DV and could represent an additional therapeutic target of SNM. Conclusion: Precise phenotyping of individuals with DV integrating clinical, urodynamic, neurophysiological, and neuropsychiatric factors is essential to predict which adults respond best to SNM/SNS. Future research should focus on establishing criteria for patient selection and designing comprehensive prospective interventional studies to assess efficacy and complications.
- 11 November 2025
- Published by Wiley in Neurourology and Urodynamics
- Vol. 45 (5) , 969-977
What Data Do We Need to Show the Cost and Clinical Effectiveness, Bearing in Mind Sustainability, of Urological Disposables in Different Patient Groups? ICI‐RS 2025
Introduction: Urological disposables, including catheters, stents, irrigation systems, and incontinence pads, are essential in functional urology but generate large volumes of nonbiodegradable waste. Intermittent self‐catheterization is the gold standard for impaired bladder emptying, while disposable pads are a frequent first‐line coping strategy for incontinence. Their widespread use presents a growing environmental challenge in healthcare. Methods: At the 2025 International Consultation on Incontinence—Research Society meeting, a dedicated session examined sustainability in urological disposables. Three questions were addressed: (1) how to define and measure sustainability, (2) whether sustainable alternatives are clinically effective and safe compared to conventional products, and for which patient groups, and (3) whether disposables are cost‐effective when environmental and health system costs are included. Results: Sustainability assessment involves life cycle analysis, carbon and water footprint evaluation, material composition, and waste generation. Existing sustainability studies are limited, non‐comparative, and methodologically inconsistent, often using variable definitions and incomplete life cycle boundaries. Reusable incontinence pads and catheters generally have a lower environmental impact than single‐use designs. Clinical outcomes, including infection rates and safety, are largely comparable between reusable and single‐use catheters, though user preference often favors single‐use products for convenience. Economic evaluations rarely incorporate environmental impacts, but proposed methods include monetizing emissions, converting environmental effects into health outcomes, and applying multi‐criteria decision‐making to integrate sustainability alongside clinical and economic performance. Conclusion: Advancing sustainable continence care requires standardised metrics, integration of environmental costs into economic evaluations, and patient‐centered product innovation, supported by collaboration between clinicians, policymakers, and industry.
- 11 November 2025
- Published by Wiley in Neurourology and Urodynamics
- Vol. 45 (5) , 969-977
What Data Do We Need to Show the Cost and Clinical Effectiveness, Bearing in Mind Sustainability, of Urological Disposables in Different Patient Groups? ICI‐RS 2025
Introduction: Urological disposables, including catheters, stents, irrigation systems, and incontinence pads, are essential in functional urology but generate large volumes of nonbiodegradable waste. Intermittent self‐catheterization is the gold standard for impaired bladder emptying, while disposable pads are a frequent first‐line coping strategy for incontinence. Their widespread use presents a growing environmental challenge in healthcare. Methods: At the 2025 International Consultation on Incontinence—Research Society meeting, a dedicated session examined sustainability in urological disposables. Three questions were addressed: (1) how to define and measure sustainability, (2) whether sustainable alternatives are clinically effective and safe compared to conventional products, and for which patient groups, and (3) whether disposables are cost‐effective when environmental and health system costs are included. Results: Sustainability assessment involves life cycle analysis, carbon and water footprint evaluation, material composition, and waste generation. Existing sustainability studies are limited, non‐comparative, and methodologically inconsistent, often using variable definitions and incomplete life cycle boundaries. Reusable incontinence pads and catheters generally have a lower environmental impact than single‐use designs. Clinical outcomes, including infection rates and safety, are largely comparable between reusable and single‐use catheters, though user preference often favors single‐use products for convenience. Economic evaluations rarely incorporate environmental impacts, but proposed methods include monetizing emissions, converting environmental effects into health outcomes, and applying multi‐criteria decision‐making to integrate sustainability alongside clinical and economic performance. Conclusion: Advancing sustainable continence care requires standardised metrics, integration of environmental costs into economic evaluations, and patient‐centered product innovation, supported by collaboration between clinicians, policymakers, and industry.
- Open Access
- 24 July 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 454
Decision-making algorithm for difficult intermittent self-catheterization: construction and validation using the Delphi method
Intermittent Self Catheterization (ISC) is the gold standard for chronic neurogenic and non neurogenic urinary retention. However, difficulties encountered may lead to poor adherence and discontinuation. This study aimed to develop and validate a decision-making algorithm to guide first and second line management of the more common difficulties reported by patients performing ISC. A survey conducted amongst patients, nurses and physicians identified the most frequent difficulties encountered with ISC. Based on a literature review and expert experience, a steering committee, composed of 14 urologists and physical medicine and rehabilitation practitioners, developed a preliminary algorithm outlining management strategies for each identified issues. The algorithm was then validated by a panel of experts through a Delphi process. Six difficulties were identified: pain, infections, bleeding, blockage, technical issues and neuro-psychological barriers. Twenty experts participated in the voting group. Of the 68 initial items, 61 were validated and included in the final algorithm (30 with a strong agreement, 31 with a relative agreement). This multidisciplinary collaborative work resulted in a validated decision-making algorithm designed to complement to existing guidelines. It supports healthcare professionals from different backgrounds in managing patients who report difficulties with ISC. The online version contains supplementary material available at 10.1007/s00345-025-05838-4.
- 24 July 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 454
Open AccessDecision-making algorithm for difficult intermittent self-catheterization: construction and validation using the Delphi method
Intermittent Self Catheterization (ISC) is the gold standard for chronic neurogenic and non neurogenic urinary retention. However, difficulties encountered may lead to poor adherence and discontinuation. This study aimed to develop and validate a decision-making algorithm to guide first and second line management of the more common difficulties reported by patients performing ISC. A survey conducted amongst patients, nurses and physicians identified the most frequent difficulties encountered with ISC. Based on a literature review and expert experience, a steering committee, composed of 14 urologists and physical medicine and rehabilitation practitioners, developed a preliminary algorithm outlining management strategies for each identified issues. The algorithm was then validated by a panel of experts through a Delphi process. Six difficulties were identified: pain, infections, bleeding, blockage, technical issues and neuro-psychological barriers. Twenty experts participated in the voting group. Of the 68 initial items, 61 were validated and included in the final algorithm (30 with a strong agreement, 31 with a relative agreement). This multidisciplinary collaborative work resulted in a validated decision-making algorithm designed to complement to existing guidelines. It supports healthcare professionals from different backgrounds in managing patients who report difficulties with ISC. The online version contains supplementary material available at 10.1007/s00345-025-05838-4.
- Open Access
- 18 April 2025
- Published by Elsevier in Annals of Physical and Rehabilitation Medicine
- Vol. 68 (4) , 101978
Developing entrustable professional activities for residents in physical and rehabilitation medicine: A Delphi study
- 18 April 2025
- Published by Elsevier in Annals of Physical and Rehabilitation Medicine
- Vol. 68 (4) , 101978
Open AccessDeveloping entrustable professional activities for residents in physical and rehabilitation medicine: A Delphi study
- Open Access
- 10 April 2025
- Published by Wiley in European Journal of Neurology
- Vol. 32 (4) , e70119
European Academy of Neurology (EAN)/European Federation of Autonomic Societies (EFAS)/International Neuro‐Urology Society (INUS) Guidelines for Practising Neurologists on the Assessment and Treatment of Neurogenic Urinary and Sexual Symptoms (NEUROGED Guidelines)
Background: Urinary and sexual symptoms are common following neurological disease, and we aimed to develop multidisciplinary inter‐society evidence‐based management guidelines.Methods: The ADAPTE framework was used, and a systematic search of guidelines published in different languages was performed. Guidelines, consensus statements, and systematic reviews were included, and guideline quality was appraised using AGREE II. Patient representatives reviewed the relevance and suitability of recommendations. A modified Delphi process integrating the Evidence to Decision framework adapted from GRADE and the Oxford Centre for Evidence Based Medicine system was used to reach consensus on recommendation wording and strength.Results: Recommendations were drafted, using guidelines/consensus statements (59 urinary, 50 sexual), systematic reviews (8 urinary, 2 sexual) and others (7 urinary,13 sexual), and wordings/strengths achieved at least 80% consensus through 2 Delphi rounds. Eleven evidence‐based recommendations, 19 good practice statements, and 8 consensus‐based recommendations were made. Individuals with neurological diseases should be asked about urogenital symptoms and undergo targeted physical examination when appropriate. Urinary symptom assessments include urinalysis, bladder diary completion, and post‐void residual volume measurement. Treatments include fluid intake optimization, pelvic physiotherapy, tibial nerve stimulation, and oral medications. Urinary retention is managed by intermittent catheterization. Antibiotics should not be recommended to treat asymptomatic bacteriuria. Suprapubic catheterization is preferred for long‐term catheterization. A comprehensive sexual history should be taken, focusing on multidimensional factors affecting sexual health. Treatments include lubricants, vibrators, and phosphodiesterase‐5 inhibitors. Red flag symptoms warrant a shared‐care approach with specialist colleagues.Conclusions: The 38 NEUROGED recommendations will guide neurologists to comprehensively manage urogenital symptoms reported by individuals with neurological diseases.
- 10 April 2025
- Published by Wiley in European Journal of Neurology
- Vol. 32 (4) , e70119
Open AccessEuropean Academy of Neurology (EAN)/European Federation of Autonomic Societies (EFAS)/International Neuro‐Urology Society (INUS) Guidelines for Practising Neurologists on the Assessment and Treatment of Neurogenic Urinary and Sexual Symptoms (NEUROGED Guidelines)
Background: Urinary and sexual symptoms are common following neurological disease, and we aimed to develop multidisciplinary inter‐society evidence‐based management guidelines.Methods: The ADAPTE framework was used, and a systematic search of guidelines published in different languages was performed. Guidelines, consensus statements, and systematic reviews were included, and guideline quality was appraised using AGREE II. Patient representatives reviewed the relevance and suitability of recommendations. A modified Delphi process integrating the Evidence to Decision framework adapted from GRADE and the Oxford Centre for Evidence Based Medicine system was used to reach consensus on recommendation wording and strength.Results: Recommendations were drafted, using guidelines/consensus statements (59 urinary, 50 sexual), systematic reviews (8 urinary, 2 sexual) and others (7 urinary,13 sexual), and wordings/strengths achieved at least 80% consensus through 2 Delphi rounds. Eleven evidence‐based recommendations, 19 good practice statements, and 8 consensus‐based recommendations were made. Individuals with neurological diseases should be asked about urogenital symptoms and undergo targeted physical examination when appropriate. Urinary symptom assessments include urinalysis, bladder diary completion, and post‐void residual volume measurement. Treatments include fluid intake optimization, pelvic physiotherapy, tibial nerve stimulation, and oral medications. Urinary retention is managed by intermittent catheterization. Antibiotics should not be recommended to treat asymptomatic bacteriuria. Suprapubic catheterization is preferred for long‐term catheterization. A comprehensive sexual history should be taken, focusing on multidimensional factors affecting sexual health. Treatments include lubricants, vibrators, and phosphodiesterase‐5 inhibitors. Red flag symptoms warrant a shared‐care approach with specialist colleagues.Conclusions: The 38 NEUROGED recommendations will guide neurologists to comprehensively manage urogenital symptoms reported by individuals with neurological diseases.